(0.08%) 5 184.99 points
(0.09%) 38 886 points
(-0.14%) 16 327 points
(0.00%) $78.48
(0.59%) $2.21
(-0.44%) $2 321.00
(-0.51%) $27.47
(2.43%) $988.30
(0.18%) $0.930
(0.79%) $10.91
(0.45%) $0.799
(-0.08%) $91.28
3 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 4.43%
Live Chart Being Loaded With Signals
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
本日の出来高 | 795 696 |
平均出来高 | 1.41M |
時価総額 | 25.33B |
EPS | $0 ( 2024-04-30 ) |
次の収益日 | ( $1.870 ) 2024-05-10 |
Last Dividend | $0.240 ( 2023-09-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 56.68 |
ATR14 | $0.0430 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Winkler Lori | Buy | 772 | Common Stock |
2024-04-01 | Winkler Lori | Sell | 215 | Common Stock |
2024-04-01 | Winkler Lori | Sell | 772 | Restricted Stock Units |
2024-03-31 | Michelson Michael W | Buy | 207 | Phantom Stock Units |
2024-03-31 | Hilado Maria Teresa | Buy | 207 | Phantom Stock Units |
INSIDER POWER |
---|
10.08 |
Last 99 transactions |
Buy: 197 885 | Sell: 163 900 |
ボリューム 相関
Zimmer Biomet Holdings 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Zimmer Biomet Holdings 相関 - 通貨/商品
Zimmer Biomet Holdings 財務諸表
Annual | 2023 |
収益: | $7.39B |
総利益: | $4.66B (63.06 %) |
EPS: | $4.91 |
FY | 2023 |
収益: | $7.39B |
総利益: | $4.66B (63.06 %) |
EPS: | $4.91 |
FY | 2022 |
収益: | $6.94B |
総利益: | $4.92B (70.90 %) |
EPS: | $1.390 |
FY | 2021 |
収益: | $7.84B |
総利益: | $5.50B (70.13 %) |
EPS: | $1.930 |
Financial Reports:
No articles found.
Zimmer Biomet Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.240 (N/A) |
$0.240 (N/A) |
$0.240 (N/A) |
$0.480 (N/A) |
$0.240 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.175 | 2012-03-28 |
Last Dividend | $0.240 | 2023-09-28 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-31 | |
Next Payout Date | N/A | |
# dividends | 48 | -- |
Total Paid Out | $10.70 | -- |
Avg. Dividend % Per Year | 0.48% | -- |
Score | 4.15 | -- |
Div. Sustainability Score | 9.49 | |
Div.Growth Potential Score | 3.69 | |
Div. Directional Score | 6.59 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.700 | 1.34% |
2013 | $0.776 | 1.18% |
2014 | $0.856 | 0.96% |
2015 | $0.856 | 0.78% |
2016 | $0.932 | 0.94% |
2017 | $0.932 | 0.93% |
2018 | $0.932 | 0.77% |
2019 | $0.932 | 0.94% |
2020 | $0.932 | 0.64% |
2021 | $0.932 | 0.63% |
2022 | $0.960 | 0.77% |
2023 | $0.960 | 0.75% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
ZTR | Dividend Royal | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.138 | 1.500 | 7.23 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0476 | 1.200 | 8.41 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0827 | 1.500 | -0.192 | -0.289 | [0.1 - 1] |
payoutRatioTTM | 0.196 | -1.000 | 8.04 | -8.04 | [0 - 1] |
currentRatioTTM | 1.613 | 0.800 | 6.93 | 5.55 | [1 - 3] |
quickRatioTTM | 0.650 | 0.800 | -0.881 | -0.704 | [0.8 - 2.5] |
cashRatioTTM | 0.146 | 1.500 | -0.303 | -0.454 | [0.2 - 2] |
debtRatioTTM | 0.271 | -1.500 | 5.49 | -8.23 | [0 - 0.6] |
interestCoverageTTM | 6.75 | 1.000 | 8.61 | 8.61 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.58 | 2.00 | 7.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.39 | 2.00 | 7.30 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.466 | -1.500 | 8.13 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.718 | 1.000 | 1.363 | 1.363 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.184 | 1.000 | 8.33 | 8.33 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.272 | 1.000 | 9.60 | 9.60 | [0.2 - 2] |
assetTurnoverTTM | 0.344 | 0.800 | -1.040 | -0.832 | [0.5 - 2] |
Total Score | 9.49 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.56 | 1.000 | 7.62 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0827 | 2.50 | -0.124 | -0.289 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.39 | 2.00 | 8.20 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.398 | 1.500 | 0.0465 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.58 | 2.00 | 7.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.196 | 1.500 | 8.04 | -8.04 | [0 - 1] |
pegRatioTTM | -0.262 | 1.500 | -5.08 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.214 | 1.000 | 7.15 | 0 | [0.1 - 0.5] |
Total Score | 3.69 |
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。